Depression, Unipolar Clinical Trial
Official title:
Ketamine + Mindfulness for Depression
In this project, the investigators will administer a single infusion of IV ketamine to depressed patients and randomize the patients to receive either a) usual/typical infusion conditions or b) mindfulness training and exercises in conjunction with the infusion. Investigators will test whether the conjunction of ketamine + mindfulness enhances the reductions in depression following a single ketamine infusion.
NOTE: The study's target sample size was revised after beginning the study, based on a revised available budget. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05114824 -
Acceptability and Feasibility of an 8-week Online Mindfulness-Based Cognitive Therapy Program Among Undergraduate Students
|
N/A | |
Not yet recruiting |
NCT05958940 -
BioClock: Bright Light Therapy for Depressive Disorders
|
N/A | |
Completed |
NCT03556735 -
Pulsed Electro Magnetic Fields (PEMF) in Depression
|
N/A | |
Completed |
NCT04916548 -
Repeated Neurocognitive Measurements in Depressed Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT05767073 -
LIVES: Personalized Lifestyle Intervention for Patients With Depression
|
N/A | |
Completed |
NCT06094907 -
Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression
|
Phase 2 | |
Completed |
NCT04121091 -
Pramipexole to Target "Anhedonic Depression"
|
Phase 2 | |
Recruiting |
NCT06092411 -
Effects of CBT and BLT in Youth With Unipolar Depression and Evening Chronotype
|
N/A | |
Enrolling by invitation |
NCT03847688 -
Machine Learning to Predict Clinical Response to TMS
|
||
Completed |
NCT02945735 -
Gaze Contingent Feedback in Major Depressive Disorder (MDD)
|
N/A | |
Recruiting |
NCT06139159 -
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
|
N/A | |
Recruiting |
NCT05011864 -
Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression
|
N/A | |
Terminated |
NCT03537547 -
Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
|
Phase 4 | |
Completed |
NCT03515733 -
PF-04995274 and Emotional Processing in Treatment Resistant Depression
|
Phase 1 | |
Not yet recruiting |
NCT05991232 -
Repeated Neurocognitive Measurements in Depressed Patients
|
Phase 1/Phase 2 | |
Completed |
NCT03516604 -
PF-04995274 and Emotional Processing in Un-medicated Depression
|
Phase 1 | |
Completed |
NCT03538275 -
Chronobiology and Depression: Circadian Analytics as a Biomarker for Depressive Subtypes
|
||
Active, not recruiting |
NCT03096886 -
Novel Neural Circuit Biomarkers of Major Depression Response to CCBT
|
N/A | |
Not yet recruiting |
NCT06462196 -
Natural History of Depression, Bipolar Disorder and Suicide Risk
|
||
Completed |
NCT01874951 -
Low-Dose Naltrexone for Depression Relapse and Recurrence
|
Phase 2 |